Aura Biosciences, Inc. (AURA) Insider Trading
Directors, officers and holders of more than 10% of AURA report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 117 transactions on file: 0 with code P, 14 with code S and 36 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Hopkins Janet Jill | Chief Medical Officer | A Award | 116,150 | Not measured | Not measured |
| Sep 1, 2026 | Abu-Absi Susan | Chief Operating Officer | A Award | 134,513 | Not measured | Not measured |
| Sep 1, 2026 | Abu-Absi Susan | Chief Operating Officer | A Award | 265,487 | Not measured | Not measured |
| Sep 1, 2026 | Elazzouzi Amy | SVP, Finance & PAO | A Award | 23,540 | Not measured | Not measured |
| Sep 1, 2026 | Kratz Erica | Chief Reg. & Quality Officer | A Award | 199,115 | Not measured | Not measured |
| Sep 1, 2026 | Hopkins Janet Jill | Chief Medical Officer | A Award | 58,850 | Not measured | Not measured |
| Sep 1, 2026 | Person Julie | Chief People Officer | A Award | 212,389 | Not measured | Not measured |
| Sep 1, 2026 | Kratz Erica | Chief Reg. & Quality Officer | A Award | 100,885 | Not measured | Not measured |
| Sep 1, 2026 | Elazzouzi Amy | SVP, Finance & PAO | A Award | 46,460 | Not measured | Not measured |
| Sep 1, 2026 | Person Julie | Chief People Officer | A Award | 107,611 | Not measured | Not measured |
| Jul 7, 2026 | Bender Jeremy | Director | A Award | 60,000 | Not measured | Not measured |
| Jul 7, 2026 | Bender Jeremy | Director | A Award | 30,000 | Not measured | Not measured |
| Jul 1, 2026 | Kilroy Conor | See Remarks | A Award | 14,858 | Not measured | Not measured |
| Jun 16, 2026 | Gibney Anthony S | See Remarks | S Sale | 12,824 | $6.42 | $82,330 |
| Jun 11, 2026 | Srivastava Sapna | Director | A Award | 30,000 | Not measured | Not measured |
| Jun 11, 2026 | Johnson David Michael | Director | A Award | 30,000 | Not measured | Not measured |
| Jun 11, 2026 | Srivastava Sapna | Director | A Award | 15,000 | Not measured | Not measured |
| Jun 11, 2026 | Bitetti Teresa Marie | Director | A Award | 15,000 | Not measured | Not measured |
| Jun 11, 2026 | Bitetti Teresa Marie | Director | A Award | 30,000 | Not measured | Not measured |
| Jun 11, 2026 | Johnson David Michael | Director | A Award | 15,000 | Not measured | Not measured |
| Jun 11, 2026 | Mattessich Antony C. | Director | A Award | 15,000 | Not measured | Not measured |
| Jun 11, 2026 | Mattessich Antony C. | Director | A Award | 30,000 | Not measured | Not measured |
| May 19, 2026 | Holles Natalie C. | See Remarks | A Award | 2,169,103 | Not measured | Not measured |
| May 19, 2026 | Holles Natalie C. | See Remarks | A Award | 553,844 | Not measured | Not measured |
| May 19, 2026 | Holles Natalie C. | See Remarks | A Award | 600,118 | Not measured | Not measured |
| May 7, 2026 | Matrix Capital Management Company, LP | 10% Owner | S Sale | 6,922,870 | $5.64 | $39,044,987 |
| Apr 16, 2026 | Kilroy Conor | See Remarks | S Sale | 11,738 | $7.02 | $82,401 |
| Mar 2, 2026 | de los Pinos Elisabet | See Remarks | A Award | 166,000 | Not measured | Not measured |
| Mar 2, 2026 | Elazzouzi Amy | SVP, Finance & PAO | A Award | 44,528 | Not measured | Not measured |
| Mar 2, 2026 | Hopkins Janet Jill | Chief Medical Officer | A Award | 89,056 | Not measured | Not measured |
| Mar 2, 2026 | Plavsic Mark | Chief Technology Officer | A Award | 62,339 | Not measured | Not measured |
| Mar 2, 2026 | Gibney Anthony S | See Remarks | A Award | 71,245 | Not measured | Not measured |
| Mar 2, 2026 | Elazzouzi Amy | SVP, Finance & PAO | A Award | 80,472 | Not measured | Not measured |
| Mar 2, 2026 | Kilroy Conor | See Remarks | A Award | 62,339 | Not measured | Not measured |
| Mar 2, 2026 | de los Pinos Elisabet | See Remarks | A Award | 249,000 | Not measured | Not measured |
| Mar 2, 2026 | Plavsic Mark | Chief Technology Officer | A Award | 112,661 | Not measured | Not measured |
| Mar 2, 2026 | Hopkins Janet Jill | Chief Medical Officer | A Award | 160,944 | Not measured | Not measured |
| Mar 2, 2026 | Kilroy Conor | See Remarks | A Award | 112,661 | Not measured | Not measured |
| Mar 2, 2026 | Gibney Anthony S | See Remarks | A Award | 128,755 | Not measured | Not measured |
| Feb 17, 2026 | de los Pinos Elisabet | See Remarks | S Sale | 47,648 | $5.06 | $241,099 |
| Feb 17, 2026 | Elazzouzi Amy | SVP, Finance & PAO | S Sale | 8,549 | $5.06 | $43,258 |
| Feb 17, 2026 | Hopkins Janet Jill | Chief Medical Officer | S Sale | 20,401 | $5.06 | $103,229 |
| Feb 17, 2026 | Plavsic Mark | Chief Technology Officer | S Sale | 15,890 | $5.05 | $80,245 |
| Feb 17, 2026 | Kilroy Conor | See Remarks | S Sale | 12,079 | $5.05 | $60,999 |
| Jan 20, 2026 | Elazzouzi Amy | SVP, Finance & PAO | S Sale | 1,581 | $4.86 | $7,684 |
| Jan 20, 2026 | de los Pinos Elisabet | See Remarks | S Sale | 16,928 | $4.86 | $82,270 |
| Nov 17, 2025 | Hopkins Janet Jill | Chief Medical Officer | S Sale | 17,109 | $5.42 | $92,731 |
| Oct 29, 2025 | Elazzouzi Amy | SVP, Finance & PAO | S Sale | 896 | $6.35 | $5,690 |
| Oct 29, 2025 | de los Pinos Elisabet | See Remarks | S Sale | 9,049 | $6.35 | $57,461 |
| Oct 16, 2025 | Plavsic Mark | Chief Technology Officer | S Sale | 12,169 | $6.35 | $77,273 |
The full Form 4 history is on the AURA company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.